Dr. Aaron Waddell received his doctoral degree in Biomedical Sciences from the University of Florida in 2021 and completed his postdoctoral research at Boston University in 2023. He is currently a clinical data scientist at the U.S. Food and Drug Administration where he performs safety data analyses on clinical trial data. His work focuses on screening clinical trial data for cases of drug-induced liver injury (DILI) and development of novel DILI screening tools that enhance efficiency of DILI review.

Dr. Yu-Han Lin currently serves as the Acting Deputy Director of R&D at Sinew Pharma Inc. He earned his PhD in Molecular Medicine through a joint program between National Yang Ming Chiao Tung University (Taiwan) and Academia Sinica (Taiwan), building upon a Master of Science in Microbiology and Immunology from Georgetown University (United States).

I am an internal medicine resident at Rutgers New Jersey Medical School

Medical Doctor, graduated from CES University (in Colombia). Currently a research fellow in the Digestive Disease Institute at Cleveland Clinic

Third-year MD/MBA student at the University of Miami Miller School of Medicine with a strong interest in clinical research, liver disease, and improving patient outcomes. I am committed to advancing meaningful research while continuing to grow as a future hepatologist.